Cover Image
市場調查報告書

寡核苷酸合成的全球市場的預測 ∼2021年:引物、探針、自訂oligo、試劑、設備

Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, Biotechnology) - Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 311580
出版日期 內容資訊 英文 249 Pages
訂單完成後即時交付
價格
Back to Top
寡核苷酸合成的全球市場的預測 ∼2021年:引物、探針、自訂oligo、試劑、設備 Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, Biotechnology) - Forecasts to 2021
出版日期: 2016年12月09日 內容資訊: 英文 249 Pages
簡介

全球寡核苷酸合成的市場預計從2016年到2021年以10.6%的年複合成長率發展,從2016年的13億3000萬美元,成長到2021年的22億美元的規模。該市場的成長,是由於醫藥品&生物科技企業的R&D支出的擴大,分子診斷部門成長需求擴大,政府對基因技術開發的投資擴大,創業投資的擴大,合成遺傳基因的需求擴大等要素而受推動

本報告提供全球寡核苷酸合成的市場調查,市場及產品與服務概要,產業趨勢,影響市場成長因素及市場機會分析,各產品&服務、用途、終端用戶、地區/主要國家的趨勢與市場規模的變化與預測,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 各產品市場
  • 各類服務市場
  • 研究用途的市場
  • 治療用途的市場
  • 各終端用戶市場
  • 地區概要

第5章 寡核苷酸合成的全球市場:概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題
  • 產業趨勢
  • 波特的五力分析
  • 供應鏈分析

第6章 寡核苷酸合成的全球市場:各產品與服務

  • 簡介
  • 合成寡核苷酸
    • 產品
      • 引物
      • 探針
      • 大規模合成oligo
      • 中規模合成寡核苷酸
      • 連接試劑、配接器
    • 服務
      • 自訂寡核苷酸
      • 事前設計完畢寡核苷酸
    • 試劑
    • 設備

第7章 寡核苷酸合成的全球市場:各用途

  • 簡介
  • 研究
    • PCR
    • 定量PCR(qPCR)
    • 定序
    • 遺傳基因合成
    • 其他的研究用途
  • 診斷
  • 治療
    • RNA干擾(RNAi)
    • 核酸核酸適體
    • DNA/反義寡核苷酸
    • 免疫療法

第8章 寡核苷酸合成的全球市場:各終端用戶

  • 簡介
  • 學術機構
  • 醫藥品、生物科技企業
  • 診斷實驗室
  • 其他

第9章 寡核苷酸合成的全球市場:地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 南美
  • 中東、非洲

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 聯盟、契約、協定、合作
    • 新產品的投入、升級、許可證
    • 擴張
    • 收購
    • 其他

第11章 企業簡介

  • 簡介
  • INTEGRATED DNA TECHNOLOGIES, INC.
  • MERCK KGAA
  • EUROFINS GENOMICS
  • THERMO FISHER SCIENTIFIC INC.
  • BIOAUTOMATION CORPORATION
  • AGILENT TECHNOLOGIES, INC.
  • EUROGENTEC S.A.
  • GENERAL ELECTRIC (GE) COMPANY
  • LGC BIOSEARCH TECHNOLOGIES, INC.
  • NITTO DENKO AVECIA INC.
    • 企業概要
    • 財務趨勢
    • 產品與服務
    • 策略
    • 近幾年的發展趨勢等

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2680

"The global oligonucleotide synthesis market is poised to reach USD 2.20 billion by 2021 from USD 1.33 billion in 2016, growing at a CAGR of 10.6% from 2016 to 2021."

Major factors contributing to the growth of the global oligonucleotide synthesis market include increasing R&D expenses in the pharmaceutical and biotechnology companies, the rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, and genetic engineering and synthetic biology also play a vital role in the development of this market. However, price erosion and a lack of regulations for therapeutic oligonucleotides could hinder the growth of this market during the forecast period.

North America commands the largest share of the global oligonucleotide synthesis market in 2016 and is expected to grow at a second-highest growth rate from 2016-2021. According to the Centers for Disease Control and Prevention (CDC), in 2016, chronic diseases accounted for 7 out of 10 deaths and 86% of healthcare costs in the U.S. It was reported that ~50% of Americans suffer from at least one chronic disease. Considering the potential of oligonucleotides (therapeutic oligonucleotides) in the treatment of chronic diseases, the oligonucleotide synthesis market is expected to flourish in the coming years, provided these drugs get rapid market approvals.

Asia-Pacific is expected to grow at the highest CAGR. The high growth in this market is attributed to growing R&D funding, rising product availability, low outsourcing costs, and increasing research activities in the region. Furthermore, factors such as the increasing applications of oligonucleotides in molecular diagnostics and therapeutics and increase in the number of oligonucleotide-related conferences in the Asia-Pacific region are further expected to drive market growth. Some prominent markets in APAC include China, India, and Japan.

Research Coverage:

This market is categorized on the basis of product & services, application, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the oligonucleotide synthesis market. The report analyzes the oligonucleotide synthesis market by product and services, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the oligonucleotide synthesis market.
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the oligonucleotide synthesis market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for oligonucleotide synthesis across geographies.
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the oligonucleotide synthesis market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY INDUSTRY INSIGHTS
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. OLIGONUCLEOTIDE SYNTHESIS MARKET OVERVIEW
  • 4.2. SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT
  • 4.3. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SERVICE
  • 4.4. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY RESEARCH APPLICATION
  • 4.5. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY THERAPEUTIC APPLICATION
  • 4.6. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER
  • 4.7. GEOGRAPHIC SNAPSHOT: OLIGONUCLEOTIDE SYNTHESIS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Technological advancements and R&D investments in synthetic biology
      • 5.2.1.2. Increasing use of synthesized oligonucleotides in molecular diagnostics and clinical applications
      • 5.2.1.3. Increasing R&D expenditure in pharmaceutical and biotechnology companies
      • 5.2.1.4. Rise in venture capital investments
      • 5.2.1.5. Growing focus on conferences to increase awareness among researchers
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Price erosion of synthesized oligos
      • 5.2.2.2. Lack of regulations for therapeutic oligos
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Emerging Asian markets
      • 5.2.3.2. Developing fields of personalized medicine and next-generation sequencing
    • 5.2.4. MARKET CHALLENGES
      • 5.2.4.1. Localization of business
      • 5.2.4.2. Large-scale synthesis of oligonucleotides
      • 5.2.4.3. Delivery of oligonucleotide drug to specific target
  • 5.3. INDUSTRY TRENDS
  • 5.4. PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1. THREAT OF NEW ENTRANTS
    • 5.4.2. THREAT OF SUBSTITUTES
    • 5.4.3. BARGAINING POWER OF SUPPLIERS
    • 5.4.4. BARGAINING POWER OF BUYERS
    • 5.4.5. INTENSITY OF COMPETITIVE RIVALRY
  • 5.5. SUPPLY CHAIN ANALYSIS
    • 5.5.1. KEY INFLUENCERS

6. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. SYNTHESIZED OLIGONUCLEOTIDES
    • 6.2.1. SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT
      • 6.2.1.1. Primers
      • 6.2.1.2. Probes
      • 6.2.1.3. Large-scale synthesis oligos
      • 6.2.1.4. Intermediate-scale synthesis oligonucleotides
      • 6.2.1.5. Linkers & Adaptors
    • 6.2.2. SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY SERVICE
      • 6.2.2.1. Custom Oligonucleotides
      • 6.2.2.2. Pre-designed oligonucleotides
    • 6.2.3. REAGENTS
    • 6.2.4. EQUIPMENT

7. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. RESEARCH
    • 7.2.1. PCR
    • 7.2.2. QPCR
    • 7.2.3. SEQUENCING
    • 7.2.4. GENE SYNTHESIS
    • 7.2.5. OTHER RESEARCH APPLICATIONS
  • 7.3. DIAGNOSTICS
  • 7.4. THERAPEUTICS
    • 7.4.1. RNAI
    • 7.4.2. NUCLEIC ACID APTAMERS
    • 7.4.3. DNA/ANTISENSE OLIGOS
    • 7.4.4. IMMUNOTHERAPY APPLICATIONS

8. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. ACADEMIC RESEARCH INSTITUTES
  • 8.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 8.4. DIAGNOSTIC LABORATORIES
  • 8.5. OTHER END USERS

9. OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. REST OF EUROPE (ROE)
  • 9.4. ASIA-PACIFIC (APAC)
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 9.5. LATIN AMERICA (LATAM)
  • 9.6. MIDDLE EAST & AFRICA (MEA)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. PARTNERSHIPS, AGREEMENTS, CONTRACTS AND COLLABORATIONS
    • 10.3.2. PRODUCT LAUNCHES, UPGRADES AND LICENSES
    • 10.3.3. EXPANSIONS
    • 10.3.4. ACQUISITIONS
    • 10.3.5. OTHERS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. INTRODUCTION
  • 11.2. INTEGRATED DNA TECHNOLOGIES, INC.
  • 11.3. MERCK KGAA
  • 11.4. EUROFINS GENOMICS
  • 11.5. THERMO FISHER SCIENTIFIC INC.
  • 11.6. BIOAUTOMATION CORPORATION
  • 11.7. AGILENT TECHNOLOGIES, INC.
  • 11.8. EUROGENTEC S.A.
  • 11.9. GENERAL ELECTRIC (GE) COMPANY
  • 11.10. LGC BIOSEARCH TECHNOLOGIES, INC.
  • 11.11. NITTO DENKO AVECIA INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. OTHER DEVELOPMENTS, BY COMPANY, 2013-2016
    • 12.3.1. PRODUCT LAUNCHES, UPGRADES, AND LICENSES
    • 12.3.2. EXPANSIONS
    • 12.3.3. ACQUISITIONS.
  • 12.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.6. AVAILABLE CUSTOMIZATIONS
  • 12.7. RELATED REPORTS
  • 12.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 2: NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 3: EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 4: ASIA-PACIFIC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 5: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 6: GLOBAL PRIMERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NORTH AMERICA: PRIMERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: EUROPE: PRIMERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: ASIA-PACIFIC: PRIMERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL PROBES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: NORTH AMERICA: PROBES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: EUROPE: PROBES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: ASIA-PACIFIC: PROBES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: NORTH AMERICA: LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: EUROPE: LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: ASIA-PACIFIC: LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPE: INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: ASIA-PACIFIC: INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL LINKERS & ADAPTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: LINKERS & ADAPTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: EUROPE: LINKERS & ADAPTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: ASIA-PACIFIC: LINKERS & ADAPTORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL CUSTOM OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: CUSTOM OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: EUROPE: CUSTOM OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: ASIA-PACIFIC: CUSTOM OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: GLOBAL PRE-DESIGNED OLIGONUCLEOTIDES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: NORTH AMERICA: PRE-DESIGNED OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: EUROPE: PRE-DESIGNED OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: ASIA-PACIFIC: PRE-DESIGNED OLIGONUCLEOTIDES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: EUROPE: OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 44: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 45: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY REGION, 2012-2019 ( USD MILLION)
  • TABLE 50: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PCR APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR QPCR APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR QPCR APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR QPCR APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR QPCR APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY REGION, 2014-2021(USD MILLION)
  • TABLE 58: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 63: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 65: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 66: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 67: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 69: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 71: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 72: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 73: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 75: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 76: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 77: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 78: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 79: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 81: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RNAI APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 82: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 83: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 84: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 85: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 86: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 87: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 88: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 89: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 90: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR IMMUNOTHERAPY APPLICATIONS, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 91: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 92: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 93: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 94: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 95: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 96: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 97: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 98: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 99: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 100: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 101: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 102: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 103: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 104: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 105: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 106: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 107: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 108: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 109: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 110: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 111: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 112: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 113: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 114: NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 115: NORTH AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 116: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 117: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 118: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 119: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 120: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 121: U.S.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 122: U.S.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 123: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 124: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 125: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: U.S.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 127: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 128: CANADA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 129: CANADA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 130: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 131: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 132: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 133: CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 134: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 135: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 136: EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 137: EUROPE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 138: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 139: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 140: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 141: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 142: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 143: GERMANY: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 144: GERMANY: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 145: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 146: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 147: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 148: GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 149: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 150: FRANCE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 151: FRANCE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 152: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 153: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 154: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 155: FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 156: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021(USD MILLION)
  • TABLE 157: U.K.: SYNTHESIZED OLIGONUCLEOTIDES MARKET, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 158: U.K.: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 159: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 160: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 161: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 162: U.K.: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 163: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 164: ROE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 165: ROE: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 166: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 167: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 168: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 169: ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 170: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 171: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 172: ASIA-PACIFIC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 173: ASIA-PACIFIC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 174: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 175: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 176: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 177: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 178: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 179: CHINA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 180: CHINA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 181: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 182: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 183: CHINA: OLIGONUCLEOTIDE MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 184: CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 185: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 186: JAPAN: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 187: JAPAN: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 188: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 189: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 190: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 191: JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 192: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 193: INDIA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 194: INDIA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 195: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 196: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 197: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 198: INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 199: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 200: ROAPAC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 201: ROAPAC: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 202: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 203: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 204: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 205: ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 206: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 207: LATIN AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 208: LATIN AMERICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 209: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 210: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 211: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 212: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 213: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT AND SERVICE, 2014-2021 (USD MILLION)
  • TABLE 214: MIDDLE EAST & AFRICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 215: MIDDLE EAST & AFRICA: SYNTHESIZED OLIGONUCLEOTIDES MARKET SIZE, BY SERVICE, 2014-2021 (USD MILLION)
  • TABLE 216: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 217: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR RESEARCH APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 218: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 219: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 220: PARTNERSHIPS, AGREEMENTS, CONTRACTS AND COLLABORATIONS (2013-2016)
  • TABLE 221: PRODUCT LAUNCHES, UPGRADES AND LICENSES (2013-2016)
  • TABLE 222: EXPANSIONS (2013-2016)
  • TABLE 223: ACQUISITIONS (2013-2016)
  • TABLE 224: OTHERS (2013-2016)
  • TABLE 225: EXCHANGE RATES (USED FOR THE CONVERSION OF EUR TO USD)
  • TABLE 226: PARTNERSHIPS, AGREEMENTS, CONTRACTS, AND COLLABORATIONS (2013-2016)
  • TABLE 227: PRODUCT LAUNCHES, UPGRADES, AND LICENSES (2013-2016)
  • TABLE 228: EXPANSIONS (2013-2016)
  • TABLE 229: ACQUISITIONS (2013-2016)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 7: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 8: SYNTHESIZED OLIGONUCLEOTIDES TO DOMINATE THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET DURING THE FORECAST PERIOD
  • FIGURE 9: INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES TO REGISTER THE HIGHEST GROWTH (2016-2021)
  • FIGURE 10: CUSTOM OLIGOS TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIGURE 11: RESEARCH APPLICATIONS TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS MARKET IN 2016
  • FIGURE 12: DIAGNOSTIC LABORATORIES END USER SEGMENT TO REGISTER THE HIGHEST CAGR (2016-2021)
  • FIGURE 13: NORTH AMERICA TO HOLD THE LARGEST SHARE IN 2016 AND ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH (2016-2021)
  • FIGURE 14: INCREASING RESEARCH ACTIVITIES AND GROWTH IN THE FIELDS OF MOLECULAR DIAGNOSTICS AND NGS ARE FUELING MARKET GROWTH
  • FIGURE 15: PRIMERS TO FORM THE MAJOR CONTRIBUTING SEGMENT OF THE SYNTHESIZED OLIGONUCLEOTIDES MARKET (2016-2021)
  • FIGURE 16: CUSTOM OLIGOS TO DOMINATE THE SYNTHESIZED OLIGONUCLEOTIDES SERVICES MARKET FROM 2016 TO 2021
  • FIGURE 17: PCR TO COMMAND THE LARGEST SHARE OF THE RESEARCH APPLICATIONS MARKET IN 2016
  • FIGURE 18: RNAI SEGMENT EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 19: DIAGNOSTIC LABORATORIES TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 20: CHINA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 21: OLIGONUCLEOTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
  • FIGURE 22: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 23: SYNTHESIZED OLIGONUCLEOTIDES TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 24: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 25: THE INTERMEDIATE-SCALE SYNTHESIS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 26: CUSTOM OLIGONUCLEOTIDES TO COMMAND THE LARGEST SHARE OF OLIGONUCLEOTIDE SYNTHESIS SERVICES MARKET IN 2016
  • FIGURE 27: NORTH AMERICA TO DOMINATE THE REAGENTS MARKET IN 2016
  • FIGURE 28: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 29: DIAGNOSTIC APPLICATIONS SEGMENT OFFERS LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 30: PCR SEGMENT TO DOMINATE THE RESEARCH APPLICATIONS MARKET IN 2016
  • FIGURE 31: ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR IN THE DIAGNOSTIC APPLICATIONS MARKET DURING 2016-2021
  • FIGURE 32: RNAI SEGMENT TO DOMINATE THE THERAPEUTIC APPLICATIONS MARKET FROM 2016 TO 2021
  • FIGURE 33: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2016 VS. 2021
  • FIGURE 34: ASIA-PACIFIC TO REGISTER HIGHEST CAGR IN THE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES
  • FIGURE 35: NORTH AMERICA TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES (2016-2021)
  • FIGURE 36: ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR IN THE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES
  • FIGURE 37: NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 38: EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 39: ASIA-PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 40: LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 41: MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT
  • FIGURE 42: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2013 AND 2016
  • FIGURE 43: MARKET EVOLUTION FRAMEWORK
  • FIGURE 44: GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 45: BATTLE FOR MARKET SHARE: PARTNERSHIPS, AGREEMENTS, CONTRACTS AND COLLABORATIONS WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 46: PRODUCT BENCHMARKING FOR TOP PLAYERS IN THE OLIGONUCLEOTIDE SYNTHESIS MARKET
  • FIGURE 47: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 48: EUROFINS SCIENTIFIC GROUP: COMPANY SNAPSHOT
  • FIGURE 49: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 50: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 51: KANEKA CORPORATION: COMPANY SNAPSHOT
  • FIGURE 52: GENERAL ELECTRIC COMPANY (GE): COMPANY SNAPSHOT
  • FIGURE 53: NITTO DENKO GROUP: COMPANY SNAPSHOT
Back to Top